SCHEMBL8285235

SCHEMBL8285235

CCc1cc2c(=O)cc(Nc3ccccc3)n(-c3ccccc3)c2nc1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE11A Q9HCR9 1/20 0.41
GAA P10253 3/20 0.39
HPGD P15428 2/20 0.39
MAPK1 P28482 2/20 0.39
CSF1R P07333 1/20 0.37
GSK3B P49841 3/20 0.37
ALDH1A1 P00352 3/20 0.36
HTT P42858 2/20 0.36
LMNA P02545 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CDK4 P11802 1/20 0.36
CCND1 P24385 1/20 0.36
CCND2 P30279 1/20 0.36
CCND3 P30281 1/20 0.36
KDM4E B2RXH2 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
ATM Q13315 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
MAPT P10636 2/20 0.35
TSHR P16473 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8286420 0.91 PDE11A (0.40) PDE11AGAAHPGDMAPK1GSK3B
SCHEMBL8287150 0.91 PDE11A (0.40) PDE11AGAAHPGDMAPK1CSF1R
SCHEMBL8287503 0.91 PDE11A (0.40) PDE11AGAAHPGDMAPK1CSF1R
SCHEMBL8285219 0.90 PDE11A (0.39) PDE11AGAAHPGDMAPK1GSK3B
SCHEMBL8286131 0.90 MAPT (0.42) PDE11AGAAHPGDMAPK1GSK3B
SCHEMBL8287585 0.89 PDE11A (0.38) PDE11AGAAHPGDMAPK1CSF1R
SCHEMBL8285233 0.89 PDE11A (0.39) PDE11AGAAHPGDMAPK1CSF1R
SCHEMBL8287892 0.89 PDE11A (0.39) PDE11AGAAHPGDMAPK1CSF1R
SCHEMBL8286134 0.88 ALDH1A1 (0.39) PDE11AGAAHPGDMAPK1GSK3B
SCHEMBL8286404 0.88 PDE11A (0.40) PDE11AGAAHPGDMAPK1CSF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed